Project Mercury’s Global Task Force (GTF) convened in Barcelona on December 7–8, bringing together international leaders in FSHD research, advocacy, and policy to chart the next phase of global collaboration. The meeting was marked by candid dialogue, strategic alignment, and renewed commitment to advancing patient-centered solutions.
Key Outcomes and Strategic Next Steps
The GTF reaffirmed its mission to accelerate readiness for FSHD therapies through coordinated global action.
A Culture of Collaboration and Transparency
Discussions reflected the depth of commitment and shared purpose among participants. The GTF emphasized the importance of regular subgroup meetings to identify gaps, foster innovation, and maintain alignment across regions and disciplines.
Looking Ahead
Project Mercury continues to evolve as a dynamic platform for global collaboration in FSHD. The Barcelona meeting reinforced the initiative’s core values: transparency, inclusivity, and strategic foresight. With new structures in place and a clear roadmap ahead, the GTF is poised to deliver meaningful impact in 2025 and beyond.
